Article
A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer.
American journal of human genetics - 10 Aug 2012
Liu Bin, Yang Lei, Huang Binfang, Cheng Mei, Wang Hui, Li Yinyan, Huang Dongsheng, Zheng Jian, Li Qingchu, Zhang Xin, Ji Weidong, Zhou Yifeng, Lu Jiachun
Abstract excerpt
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2) may promote cancer development and progression by inducing tumorigenesis and drug resistance. To assess whether the copy-number variation g.CNV-30450 located in the MAPKAPK2 promoter has any effect on lung cancer risk or progn...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
